Molecular genetics of prostate cancer: new prospects for old challenges
MM Shen, C Abate-Shen - Genes & development, 2010 - genesdev.cshlp.org
Despite much recent progress, prostate cancer continues to represent a major cause of
cancer-related mortality and morbidity in men. Since early studies on the role of the …
cancer-related mortality and morbidity in men. Since early studies on the role of the …
The impact of translocations and gene fusions on cancer causation
F Mitelman, B Johansson, F Mertens - Nature Reviews Cancer, 2007 - nature.com
Chromosome aberrations, in particular translocations and their corresponding gene fusions,
have an important role in the initial steps of tumorigenesis; at present, 358 gene fusions …
have an important role in the initial steps of tumorigenesis; at present, 358 gene fusions …
The oncogene ERG: a key factor in prostate cancer
P Adamo, MR Ladomery - Oncogene, 2016 - nature.com
ETS-related gene (ERG) is a member of the E-26 transformation-specific (ETS) family of
transcription factors with roles in development that include vasculogenesis, angiogenesis …
transcription factors with roles in development that include vasculogenesis, angiogenesis …
Role of the TMPRSS2-ERG gene fusion in prostate cancer
TMPRSS2-ERG gene fusions are the predominant molecular subtype of prostate cancer.
Here, we explored the role of TMPRSS2-ERG gene fusion product using in vitro and in vivo …
Here, we explored the role of TMPRSS2-ERG gene fusion product using in vitro and in vivo …
Recurrent gene fusions in prostate cancer
The discovery of recurrent gene fusions in a majority of prostate cancers has important
clinical and biological implications in the study of common epithelial tumours. Gene fusion …
clinical and biological implications in the study of common epithelial tumours. Gene fusion …
Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer
The histone methyltransferase DOT1L methylates lysine 79 (K79) on histone H3 and is
involved in Mixed Lineage Leukemia (MLL) fusion leukemogenesis; however, its role in …
involved in Mixed Lineage Leukemia (MLL) fusion leukemogenesis; however, its role in …
Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical …
W Weichert, A Röske, V Gekeler, T Beckers… - British journal of …, 2008 - nature.com
High activity of histone deacetylases (HDACs) causes epigenetic alterations associated with
malignant cell behaviour. Consequently, HDAC inhibitors have entered late-phase clinical …
malignant cell behaviour. Consequently, HDAC inhibitors have entered late-phase clinical …
Identification of fusion genes in breast cancer by paired-end RNA-sequencing
H Edgren, A Murumagi, S Kangaspeska, D Nicorici… - Genome biology, 2011 - Springer
Background Until recently, chromosomal translocations and fusion genes have been an
underappreciated class of mutations in solid tumors. Next-generation sequencing …
underappreciated class of mutations in solid tumors. Next-generation sequencing …
Common gene rearrangements in prostate cancer
Prostate cancer is a common heterogeneous disease, and most patients diagnosed in the
post prostate-specific antigen (PSA) era present with clinically localized disease, the …
post prostate-specific antigen (PSA) era present with clinically localized disease, the …
ETS gene fusions in prostate cancer: from discovery to daily clinical practice
CONTEXT: In 2005, fusions between the androgen-regulated transmembrane protease
serine 2 gene, TMPRSS2, and E twenty-six (ETS) transcription factors were discovered in …
serine 2 gene, TMPRSS2, and E twenty-six (ETS) transcription factors were discovered in …